Vaccine Candidate FluMos-v2 Targets Six Flu Strains A Phase 1 trial for the investigational universal influenza vaccine candidate, FluMos-v2, has started at the National Institutes…
According to a recent paper in Biology Methods and Protocols, published by Oxford University Press, researchers studying SARS-CoV-2 may have developed new methods to administer vaccines…
Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis….
New research presents a potential solution to a bacterial infection that impacts 160 million people globally. A new study in Nature Communications reveals that a…
Scientists from the University of Montana, along with their partners, are close to initiating human trials for vaccines designed to prevent overdoses from fentanyl and…
A Japanese research team has introduced the ‘Purecap’ method, enabling the production of highly pure mRNA vaccines. A research group from Japan has developed a…
A study of older U.S. adults led by researchers at Brown University found that the risk of negative effects of both mRNA vaccines is exceptionally…
A vaccine that targets inflamed brain cells associated with Alzheimer’s disease could possibly modify or prevent the disease, according to preliminary research. A novel vaccine…
The global landscape underwent a sudden transformation in March 2020, when nations worldwide imposed lockdown measures to curb the swift proliferation of COVID-19. This often…
Cancer patients saw a significant decline in COVID-related hospitalizations and mortality following the rollout of COVID-19 vaccines in the first panoramic study of its kind….
Proteins that encapsulate viruses can be molded into defined shapes using DNA and RNA origami nanostructures. Bioengineers have discovered a method to customize the size…
The results, which have been published in the journal Nature Chemical Biology, lay the groundwork for the future development of unique vaccines and immunotherapies. Amino…
An MIT research team has made a breakthrough in improving the effectiveness of engineered T cells, or chimeric antigen receptor (CAR) T cells, in treating…
A recent study by the Annenberg Public Policy Center reveals a general lack of knowledge among Americans about RSV (Respiratory Syncytial Virus). The survey indicates…
Incorporating a personalized mRNA vaccine, designed to match an individual’s tumor genetics, into standard immunotherapy substantially boosts survival rates and reduces the recurrence of high-risk…
New study suggests some vaccines could induce a protective shift in the microorganisms that live with a host organism. A human or animal’s microbiome —…
Nebraska scientists have used a data-driven technique, Epigraph, to create a potentially universal vaccine against swine flu. Long-term trials on hogs showed it to be…
By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a Scripps Research team identified new antibodies and vaccine targets….
